Catalyst Wire Dossier Catalyst Wire Dossier

Ketotifen 4.0% patch

ketotifen · Senju USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ketotifen 4.0% patch, covering 2023-08-04 to 2023-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis [Phase 2]

See pricing